Signed in as:
filler@godaddy.com
In the media
Wendy Brown honored by Georgia Tech in 40 Under 40 Class of 2024
From the Georgia Tech Alumni Association, July 17, 2024:
Wendy Brown, Cartilage Inc.'s Co-founder and Director of Regulatory and Clinical Affairs, was honored by her alma mater, the Georgia Institute of Technology, as one of this year's class of 40 Under 40 alumni.
"The 2024 class of 40 Under 40 highlights the work of Yellow Jackets around the globe whose innovative spirits inspire us all. Collectively, the honorees are building roads, shaping the future of nuclear energy, advancing space exploration, improving outcomes in individuals with mobility impairments, creating inventions that change the world, and impacting every aspect of life." Wendy's favorite Tech memory is from her first football game as a Goldrush dancer, standing in the end zone for the flyover during the national anthem. She remembers thinking in that moment that "this is the first day of the rest of my life" and that the possibilities of her future are endless. Please join the Cartilage Inc. team in congratulating Wendy for this distinguished honor!
To learn more about the class, visit this interactive tableau.
Ryan Donahue honored by University of Miami in 30 Under 30 Class of 2024
From the University of Miami Alumni Association, June 27, 2024: Ryan Donahue, Cartilage Inc.'s Co-founder and Director of Director of Preclinical Translation, was honored by his alma mater, the University of Miami as one of this year's class of 30 Under 30 alumni. The UMiami Young Alumni Leadership Council review committee selected finalists based on the impact made on their profession, community, and the University of Miami. Ryan cited his
"brightest moment at the U" as his freshman year drew to a close, "marking the start of a journey filled with dynamic involvement and leadership opportunities across campus. From obtaining a resident assistant role in Hecht Residential College to earning an appointed position on the Student Government’s Executive Board, I was excited by the possibilities unfolding for me at the U." Huge congratulations to Ryan for this well-deserved honor!
The horrors of TMJ: Chronic pain, metal jaws, and futile treatments
From CBS, April 4, 2024: "These are some of the horrors of temporomandibular joint disorders, known as TMJ or TMD, which afflict up to 33 million Americans, according to the National Institutes of Health. Dentists have attempted to heal TMJ patients for close to a century, and yet the disorders remain misunderstood, under-researched, and ineffectively treated, according to an investigation by KFF Health News and CBS News." Dr. Kyriacos Athanasiou, Distinguished Professor of Biomedical Engineering at UCI and Cartilage Inc.'s Founder and Scientific Advisor, was interviewed for this news feature.
Cartilage Inc. Receives STTR Grant from NIH
September 21, 2023: Cartilage Inc. received a $252,000 Phase I Small Business Technology Transfer (STTR) grant from the National Institutes of Health (NIH). This grant will investigate their injectable cartilage implant, Chondrofluid®, for arthroscopic repair of knee cartilage. This is Cartilage Inc.'s third federal award. Dr. Dean Wang, UCI's Chief of Sports Medicine Division and Cartilage Inc.'s Orthopaedic Surgery Consultant, serves as Principal Investigator for this grant.
Patent Granted for Foundational Technology
July 11, 2023: A patent for Methods and Systems for Conserving Highly Expanded Cells, a foundational technology underlying Hyaleon® and Chondrofluid®, was issued by the United States Patent and Trademark Office (USPTO).
Jaw Joint Implant Co. from UCI Awarded $6M
From OCBJ, May 22, 2023: Cartilage Inc., a biomedical startup from the University of California Irvine, is developing a product that will restore TMJ function by regenerating missing tissue and repairing defects in the jaw joint. (Page 16: Startups & Innovations)
CIRM invests $89 million in stem cell and gene therapy research
From CIRM, April 27, 2023: The Board of the California Institute for Regenerative Medicine (CIRM) approved investing nearly $89 million in projects from its Clinical and Translation programs at its April meeting. Nearly $39 million will support four projects in the agency’s Clinical program, which speeds up support and provides funding for eligible stem cell and gene therapy-based projects through any stage of clinical trial activity. Included in the awards is a $6,000,000 grant to Kyriacos Athanasiou to perform IND-enabling studied for Hyaleon® for treatment of the TMJ disc complex.
Cartilage Inc. Receives Second SBIR Grant for Glue that Holds it All Together
From UCI Beall Applied Innovation News, March 31, 2021: "UC Irvine (UCI) startup Cartilage Inc., a Wayfinder team, recently received a $256,000 National Science Foundation (NSF) phase one Small Business Innovation Researcher (SBIR) grant. The funds will be used to develop their latest product, a special injectable cartilage glue designed to fix Cartilage’s and other commercially available implants and to help with the integration and healing of cartilage implants into surrounding tissues. This is the second SBIR grant the team has received in less than six months." Dr. Wendy Brown, Cartilage Inc.'s Director of Regulatory and Clinical Affairs, serves as Principal Investigator for this grant.
UCI Startup Cartilage Inc. Receives $252k to Address Cartilage Healing
From UCI Beall Applied Innovation News, October 20, 2020: "UC Irvine startup Cartilage Inc., a Wayfinder team, recently received a Phase I $252,000 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). The startup will use this grant to investigate the feasibility of their product Hyaleon®, a scaffold-free, tissue-engineered cartilage implant, capable of healing both large and small cartilage defects." Dr. Wendy Brown, Cartilage Inc.'s Director of Regulatory and Clinical Affairs, serves as Principal Investigator for this grant.